Literature DB >> 15728477

Differential effects of IL-21 during initiation and progression of autoimmunity against neuroantigen.

Timothy L Vollmer1, Ruolan Liu, Mary Price, Susan Rhodes, Antonio La Cava, Fu-Dong Shi.   

Abstract

The cytokine IL-21 is closely related to IL-2 and IL-15, a cytokine family that uses the common gamma-chain for signaling. IL-21 is expressed by activated CD4(+) T cells. We examined the role of IL-21 in the autoimmune disease experimental autoimmune encephalomyelitis (EAE), an animal model for human multiple sclerosis. IL-21 administration before induction of EAE with a neuroantigen, myelin oligodendrocyte glycoprotein peptide 35-55, and adjuvant enhanced the inflammatory influx into the CNS, as well as the severity of EAE. Autoreactive T cells purified from IL-21-treated mice transferred more severe EAE than did the control encephalitogenic T cells. No such effects were observed when IL-21 was administered after EAE progressed. Additional studies demonstrated that IL-21 given before the induction of EAE boosted NK cell function, including secretion of IFN-gamma. Depletion of NK cells abrogated the effect of IL-21. Therefore, IL-21, by affecting NK cells, has differential effects during the initiation and progression of autoimmune responses against neuroantigens.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15728477     DOI: 10.4049/jimmunol.174.5.2696

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

Review 1.  Natural killer cells and their receptors in multiple sclerosis.

Authors:  Gurman Kaur; John Trowsdale; Lars Fugger
Journal:  Brain       Date:  2012-06-25       Impact factor: 13.501

Review 2.  The innate immune system in demyelinating disease.

Authors:  Lior Mayo; Francisco J Quintana; Howard L Weiner
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

3.  Serum IL-21 levels decrease with glucocorticoid treatment in myasthenia gravis.

Authors:  Y Li; V K Rauniyar; W F Yin; B Hu; S Ouyang; B Xiao; H Yang
Journal:  Neurol Sci       Date:  2013-05-26       Impact factor: 3.307

4.  Investigation of IL-21 gene polymorphisms (rs2221903, rs2055979) in cases with multiple sclerosis of Azerbaijan, Northwest Iran.

Authors:  Tohid Gharibi; Tohid Kazemi; Mohammad Reza Aliparasti; Mehdi Farhoudi; Shohreh Almasi; Rashedeh Dehghanzadeh; Narges Seyfizadeh; Zohreh Babaloo
Journal:  Am J Clin Exp Immunol       Date:  2015-07-05

Review 5.  Role of the innate immune system in the pathogenesis of multiple sclerosis.

Authors:  Roopali Gandhi; Alice Laroni; Howard L Weiner
Journal:  J Neuroimmunol       Date:  2010-04-15       Impact factor: 3.478

Review 6.  Interleukin-21: a double-edged sword with therapeutic potential.

Authors:  Rosanne Spolski; Warren J Leonard
Journal:  Nat Rev Drug Discov       Date:  2014-04-22       Impact factor: 84.694

Review 7.  Multiple sclerosis and the role of immune cells.

Authors:  Rune A Høglund; Azzam A Maghazachi
Journal:  World J Exp Med       Date:  2014-08-20

8.  Intravenous transfer of apoptotic cell-treated dendritic cells leads to immune tolerance by blocking Th17 cell activity.

Authors:  Fang Zhou; Elisabetta Lauretti; Antonio di Meco; Bogoljub Ciric; Patricia Gonnella; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  Immunobiology       Date:  2013-03-01       Impact factor: 3.144

9.  Lithium prevents and ameliorates experimental autoimmune encephalomyelitis.

Authors:  Patrizia De Sarno; Robert C Axtell; Chander Raman; Kevin A Roth; Dario R Alessi; Richard S Jope
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

10.  Lipoic acid stimulates cAMP production via the EP2 and EP4 prostanoid receptors and inhibits IFN gamma synthesis and cellular cytotoxicity in NK cells.

Authors:  Sonemany Salinthone; Robynn V Schillace; Gail H Marracci; Dennis N Bourdette; Daniel W Carr
Journal:  J Neuroimmunol       Date:  2008-06-17       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.